Invention Grant
- Patent Title: Telomerase activating compounds and methods of use thereof
-
Application No.: US14077989Application Date: 2013-11-12
-
Publication No.: US09670138B2Publication Date: 2017-06-06
- Inventor: Esther Priel
- Applicant: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
- Applicant Address: IL Beer Sheva
- Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
- Current Assignee: BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
- Current Assignee Address: IL Beer Sheva
- Agency: Lucas & Mercanti, LLP
- Main IPC: C07C215/80
- IPC: C07C215/80 ; A01N57/00 ; A61K31/535 ; A61K31/497 ; A01N43/40 ; A61K31/445 ; A61K31/03 ; A61K31/05 ; A61K31/055 ; A61K31/136 ; A61K31/66 ; A61K31/695 ; C07C215/50 ; C07D213/16 ; C07D213/30 ; C07D295/096 ; C07C43/225 ; C07D295/135 ; C07C39/367 ; C07C43/23 ; C07F9/50
Abstract:
The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
Public/Granted literature
- US20140142067A1 TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF Public/Granted day:2014-05-22
Information query
